UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Smart cup: A minimally-instrumented, smartphone-based point-of-care molecular diagnostic device

Sensors and actuators. B, Chemical, 2016-06, Vol.229, p.232-238

2016

Volltextzugriff (PDF)

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

PLoS pathogens, 2020-07, Vol.16 (7), p.e1008795-e1008795

2020

Volltextzugriff (PDF)

Status of prophylactic and therapeutic genital herpes vaccines

Current opinion in virology, 2014-06, Vol.6, p.6-12

2014

Volltextzugriff (PDF)

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs

PLoS pathogens, 2017-01, Vol.13 (1), p.e1006141-e1006141

2017

Volltextzugriff (PDF)

Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs

PLoS pathogens, 2018-05, Vol.14 (5), p.e1007095-e1007095

2018

Volltextzugriff (PDF)

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1

Viruses, 2023-06, Vol.15 (7), p.1483

2023

Volltextzugriff (PDF)

The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo

Journal of Virology, 2011-04, Vol.85 (7), p.3239-3249

2011

Volltextzugriff (PDF)

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

Human vaccines & immunotherapeutics, 2020-09, Vol.16 (9), p.2109-2113

2020

Volltextzugriff (PDF)

Successful application of prime and pull strategy for a therapeutic HSV vaccine

npj vaccines, 2019-08, Vol.4 (1), p.33-33, Article 33

2019

Volltextzugriff (PDF)

Anterograde Spread of Herpes Simplex Virus Type 1 Requires Glycoprotein E and Glycoprotein I but Not Us9

Journal of Virology, 2009-09, Vol.83 (17), p.8315-8326

2009

Volltextzugriff (PDF)

Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine

Viruses, 2022-03, Vol.14 (3), p.540

2022

Volltextzugriff (PDF)

Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone

Journal of Virology, 2011-10, Vol.85 (20), p.10472-10486

2011

Volltextzugriff (PDF)

Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D

Expert review of vaccines, 2014-12, Vol.13 (12), p.1475-1488

2014

Volltextzugriff (PDF)

A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model

Human vaccines & immunotherapeutics, 2017-12, Vol.13 (12), p.2785-2793

2017

Volltextzugriff (PDF)

Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs

Journal of Virology, 2014-02, Vol.88 (4), p.2000-2010

2014

Volltextzugriff (PDF)

Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread

Journal of Virology, 2012-04, Vol.86 (8), p.4586-4598

2012

Volltextzugriff (PDF)

Taking aim at novel vaccines market

Human vaccines, 2009-10, Vol.5 (10), p.654-657

Awasthi, Sita

2009

Volltextzugriff (PDF)

Next generation of human vaccines: What does the future hold?

Human vaccines, 2008-09, Vol.4 (5), p.344-346

Awasthi, Sita

2008

Volltextzugriff (PDF)

An mRNA vaccine to prevent genital herpes

Translational research : the journal of laboratory and clinical medicine, 2022-04, Vol.242, p.56-65

2022

Volltextzugriff (PDF)

Analysis of Splice Variants of the Immediate-Early 1 Region of Human Cytomegalovirus

Journal of Virology, 2004-08, Vol.78 (15), p.8191-8200

2004

Volltextzugriff (PDF)

Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine

The Journal of infectious diseases, 2014-08, Vol.210 (4), p.571-575

2014

Volltextzugriff (PDF)

Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes

Journal of virology, 2014-08, Vol.88 (15), p.8421-8432

2014

Volltextzugriff (PDF)

Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity

Journal of virology, 2020-05, Vol.94 (11)

2020

Volltextzugriff (PDF)

A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection

Vaccine, 2019-01, Vol.37 (4), p.664-669

2019

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(61)
Berichte
(3)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(46)
Animals
(30)
Virology
(22)
Female
(20)
Mice
(18)
Herpes Genitalis - Prevention & Control
(17)
Humans
(16)
Immunology
(16)
Guinea Pigs
(14)
Microbiology
(14)
Immunization
(13)
Infections
(13)
Viral Envelope Proteins - Immunology
(13)
Biological And Medical Sciences
(12)
Glycoproteins
(12)
Vaccines
(12)
Glycoprotein D
(11)
Herpes Viruses
(10)
Immune Evasion
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Smart cup: A minimally-instrumented, smartphone-based point-of-care molecular diagnostic device

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

Status of prophylactic and therapeutic genital herpes vaccines

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs

Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1

The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

Successful application of prime and pull strategy for a therapeutic HSV vaccine

Anterograde Spread of Herpes Simplex Virus Type 1 Requires Glycoprotein E and Glycoprotein I but Not Us9

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs

Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine

Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone

Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D

A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model

Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs

Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread

Taking aim at novel vaccines market

Next generation of human vaccines: What does the future hold?

An mRNA vaccine to prevent genital herpes

Analysis of Splice Variants of the Immediate-Early 1 Region of Human Cytomegalovirus

Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine

Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes

Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity

A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection

Suchergebnisse filtern